Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05142332
Other study ID # 21-34004
Secondary ID R01AI166967-01
Status Terminated
Phase N/A
First received
Last updated
Start date December 6, 2021
Est. completion date August 30, 2022

Study information

Verified date November 2023
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this research is to increase COVID-19 vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of COvid-19 VA(X)ccination in the Emergency Department - PROCOVAXED) that will address barriers to COVID-19 vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROCOVAXED platforms in six EDs to determine whether their implementation is associated with greater COVID-19 vaccine acceptance and uptake in ED Usual Source of Care Patients.


Description:

The investigator's preliminary work research at 15 ED sites across the US indicates that ED Usual Source of Care patients have particular health care access barriers, needs, and perceptions about vaccines (vaccine hesitancy) that require specific review beyond traditional (non-ED user) community engagement techniques. To gain insight about messaging that effectively addresses these barriers, needs, and perceptions, the investigators will conduct one on one interviews and focus group meetings with ED Usual Source of Care Patients and community partners. At five safety net EDs (Zuckerberg San Francisco General, Thomas Jefferson University Hospital [Philadelphia], Methodist Hospital [Philadelphia], Harborview Medical Center [Seattle], and Duke University Medical Center [Durham, NC], the investigators will conduct a cluster-randomized, controlled trial of implementation of PROCOVAXED platforms, with COVID-19 and influenza vaccine acceptance rates on post-intervention ED surveys as the primary outcomes. Hypothesis: Implementation of PROCOVAXED platforms in EDs will be associated with increased acceptance of COVID-19 vaccines in ED patients. One month after subjects' index ED visit enrollment in our PROCOVAXED implementation trial, the investigators will conduct electronic health record review and phone follow-up surveys to determine ED patient uptake (receipt) of COVID-19 vaccines. Hypothesis: Implementation of PROCOVAXED platforms in EDs will be associated with greater COVID-19 vaccine uptake in ED patients. The investigators will conduct a cluster-randomized, controlled trial (RCT) of implementation of our PROCOVAXED platforms in 5 high-volume, safety net hospital EDs, testing two hypotheses that implementation of PROCOVAXED platforms will be associated with increased acceptance and uptake of COVID-19 vaccines in ED Usual Source of Care Patients.


Recruitment information / eligibility

Status Terminated
Enrollment 541
Est. completion date August 30, 2022
Est. primary completion date July 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults (>18 years of age) patients who are receiving care at participating Emergency Departments and have not yet received a COVID-19 vaccine (PROCOVAXED) Exclusion Criteria: - major trauma patients - patients transferred from another hospital, chronic care facility, nursing home or hospice, - patients unable to participate in an interview because of intoxication, altered mental status or critical illness - incarcerated patients - patients on psychiatric holds - patients who have received a COVID-19 vaccine - under suspicion for acute COVID-19 illness

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Covid-19 vaccine education materials
videos and flyers containing Covid-19 vaccine educational information

Locations

Country Name City State
United States Duke University Hospital Durham North Carolina
United States Jefferson Methodist Hospital Philadelphia Pennsylvania
United States Jefferson Torresdale Hospital Philadelphia Pennsylvania
United States Thomas Jefferson University Hospital Philadelphia Pennsylvania
United States San Francisco General Hospital Emergency Department San Francisco California
United States University of California, San Francisco - Parnassus San Francisco California
United States University of Washington-Harborview Emergency Department Seattle Washington

Sponsors (5)

Lead Sponsor Collaborator
University of California, San Francisco Duke University, National Institute of Allergy and Infectious Diseases (NIAID), Thomas Jefferson University, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Covid-19 Vaccine Acceptance in the Emergency Department: PROCOVAXED Participant acceptance of the COVID-19 vaccine assessed by the question "Would you accept the COVID-19 vaccine in the emergency department today if your doctor or provider asked you to get it?" The response choices for this question are "Yes", "No", and "No, but I might consider getting it at some other time".
This question will be asked once at the end of the Emergency Department visit.
Within 6 hours of intervention
Primary Covid-19 Vaccine Uptake: PROCOVAXED Participation uptake of the COVID-19 vaccine 30 days after enrollment assessed by confirmation of receipt of vaccine in one of 3 ways:
Receipt in emergency department during index (enrollment) visit
Electronic health record review 30 days after index visit
Follow up phone call to participant at 28 to 30 days - We are asking patients if they received a COVID-19 vaccine since their index emergency department visit.
Within 30 days of intervention
See also
  Status Clinical Trial Phase
Completed NCT05994820 - Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India N/A
Completed NCT05537441 - Precision Vaccine Promotion in Underserved Populations N/A
Recruiting NCT05998824 - COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease N/A
Terminated NCT05167422 - Trusted Messenger Intervention N/A
Completed NCT04939506 - COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana N/A
Recruiting NCT05787015 - Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy N/A
Enrolling by invitation NCT06062056 - Motivational Interviewing for Vaccine Uptake in Latinx Adults N/A
Recruiting NCT05473936 - A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination N/A
Not yet recruiting NCT05531058 - The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy N/A
Not yet recruiting NCT05120817 - Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy N/A
Completed NCT05206669 - Testing Messages to Promote HPV Vaccination N/A
Completed NCT06155877 - Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents N/A
Completed NCT06124131 - Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening N/A
Recruiting NCT06417762 - Dime La VerDAD: Verify, Debunk, and Disseminate N/A
Recruiting NCT06297876 - COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color N/A
Enrolling by invitation NCT06156228 - Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos N/A
Recruiting NCT05042011 - Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
Not yet recruiting NCT06374134 - The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States
Completed NCT01385501 - Educational Intervention to Improve Vaccine Acceptance N/A
Completed NCT05582564 - The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial N/A